mja.com.au | The Medical Journal of Australia

Home | Issues | MJA shop | MJA Careers | Contact | Topics | Search | RSS  | Login | Buy full access

→ Next article in this issue

→ Previous article in this issue

→ Contents list for this issue

→ More articles on Rheumatology

→ More articles on Economics

→ Pdf version of this article

            Tweet



Matters Arising

Can we reduce disease burden from osteoarthritis?

MJA 2004; 181 (6): 338-340
An article in the recent Bone and Joint Disorders Supplement presented a measure for translating trial outcomes into a quality-of-life (utility) scale and comparing the cost effectiveness of current interventions. Both the measure and the cost-effectiveness analysis raised questions. (Med J Aust 2004; 180 (5 Suppl): S11-S17)

See Letters:

→ Use of the TTU is questionable

→ TTU is valuable for comparing disparate management options

→ Cost-effectiveness findings not based on available evidence

→ Making all data publicly available would be welcome

©The Medical Journal of Australia 2004 www.mja.com.au ISSN: 0025-729X


Home | Issues | MJA shop | Terms of use | MJA Careers | More... | Contact | Topics | Search | RSS 

mja.com.au | The Medical Journal of Australia